v3.26.1
Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2026
Summary of Significant Accounting Policies [Line Items]  
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table represents the Company’s fair value hierarchy of its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2026 and December 31, 2025.

 

    June 30, 2026     December 31, 2025  
Description   Level 1     Level 2     Level 3     Level 1     Level 2     Level 3  
Short-term investments   $ 10,353,040     $          -     $ -     $ 11,345,187     $          -     $ -  
Non-traded equity securities   $ -     $ -     $ 60,000     $ -     $ -     $ 180,000  

 
Schedule of Revenue

During the three and six months ended June 30, 2026 and 2025, revenues consisted of the following:

 

    For the
Three Months Ended
June 30,		     For the
Six Months Ended
June 30,		  
    2026     2025     2026     2025  
Revenue from administrative services   $ 1,737,052     $ 170,398     $ 2,982,961     $ 192,950  
Revenue from the sale of health coaching packages     -       -       -       1,124  
Revenue from the sale of subscriptions     720,305       556       1,283,763       607  
Revenue from sale of in-game items     -       17       -       22  
Total revenues   $ 2,457,357     $ 170,971     $ 4,266,724     $ 194,703  
Schedule of Deferred Revenue

For the six months ended June 30, 2026 and 2025, deferred revenue activity consisted of the following:

 

    For the
Six Months
Ended
June 30,
2026		     For the
Six Months
Ended
June 30,
2025		  
Balance – beginning of period   $ 130,054     $ 1,126  
Additions     362,532       566  
Recognized as revenue     (130,054 )     (1,126 )
Balance – end of period   $ 362,532     $ 566  
Schedule of Common Stock Equivalents Excluded from Computation of Diluted Shares Outstanding

During the three and six months ended June 30, 2026 and 2025, the following common stock equivalents were excluded from the computation of diluted shares outstanding as they would have had an anti-dilutive impact on the Company’s net loss.

 

    June 30,  
    2026     2025  
Common stock equivalents:            
Warrants     4,509,259       4,509,259  
Stock options     284,084       139,084  
Total     4,793,343       4,648,343  
Equity Securities [Member]  
Summary of Significant Accounting Policies [Line Items]  
Schedule of Investment in Non-Traded Equity Securities

The following table summarizes activity in the Company’s investment in non-traded equity securities, at fair value for the periods presented:

 

    Six Months
Ended
June 30,		     Six Months
Ended
June 30,		  
    2026     2025  
Balance, beginning of period   $ 180,000     $ 199,998  
Unrealized loss on non-traded equity securities     (120,000 )     -  
Balance, end of period   $ 60,000     $ 199,998